# Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans

> **NCT05073237** · PHASE2 · WITHDRAWN · sponsor: **VA Office of Research and Development**

## Conditions studied

- Menopause
- Prediabetes
- Obesity

## Interventions

- **OTHER:** Placebo
- **DRUG:** conjugated estrogens/bazedoxifene (CE/BZA)

## Key facts

- **NCT ID:** NCT05073237
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-04-08
- **Primary completion:** 2024-04-08
- **Final completion:** 2024-04-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** withdrawn
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05073237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05073237, "Effects of Novel Estrogens on Glucose and Lipids in Postmenopausal Prediabetic Women Veterans". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05073237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*